Navigation Links
GeoVax Labs, Inc. Reports Data on Prototype Adjuvant - Supplemented HIV Vaccine Tested in Preclinical Animal Studies
Date:2/18/2010

ATLANTA, Feb. 18 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX) (the "Company"), an Atlanta-based, biopharmaceutical company developing vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus), today announced that it presented the results of a preclinical study on a prototype HIV/AIDS vaccine at the Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco.

The oral presentation, "Preclinical Studies on DNA/MVA Vaccines: Co-expressed GM-CSF, a Strong Adjuvant for Prevention of Infection," was presented by Dr. Harriet Robinson, Chief Scientific Officer for GeoVax and developer of the Company's vaccines. The study investigated the use of GM-CSF (granulocyte/macrophage colony-stimulating factor) as an adjuvant with the DNA prime for the GeoVax DNA/MVA vaccine for prevention of HIV/AIDS.

Adjuvants are agents that can increase the potency and effectiveness of a vaccine. GeoVax's work on adjuvants started in 2007. At that time, the National Institutes of Health (NIH) granted the company $15 million over five years to fund the search for any benefit derived from the use of adjuvants.  Results using GM-CSF showed protection from infection from simian immunodeficiency virus (SIV-monkey version of the HIV virus) in 70% of the seven exposed animals after 12 weekly exposures to the SIV virus.

"This is the highest level for prevention of an immunodeficiency virus infection ever reported in a non-human primate model," said Dr. Robinson. "We and other scientists originally thought it very difficult, even impossible, to completely prevent SIV infections. But based on the results from this study, we are now hopeful that our DNA/MVA vaccine supplemented wi
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. GeoVax Labs, Inc. Second Quarter Financial Results and Operational Update
2. U.S. Government Awards $15 Million Grant to GeoVax Labs HIV/AIDS Vaccine Program
3. GeoVax Further Strengthens Management Team
4. GeoVax Labs, Inc. Announces Six Month Financial Results and Provides Operational Update
5. GeoVax Labs, Inc. Information To Be Available Through Standard & Poors Market Access Program
6. GeoVax Presents Data at AIDS Vaccine 2008 Conference
7. GeoVaxs DNA and MVA Vaccines Shipped to HIV Vaccine Trials Network for Use in the Upcoming Phase 2a Trial
8. GeoVax Labs, Inc. Announces Third Quarter 2008 Financial Results and Provides Operational Update
9. GeoVax to Present at the BIO CEO & Investor Conference 2009
10. GeoVax to Webcast Its Presentation at the BIO CEO & Investor 2009 Conference
11. GeoVax Update Provided at the BIO CEO & Investor Conference 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... Marianjoy Rehabilitation Hospital ... and hand impairments by acquiring the Armeo®Spring arm ... network site. , Secured through grant support of ... treatment option for patients with upper extremity weakness ... one of just four Illinois providers offering treatment ...
(Date:5/1/2015)... leading North American IT solutions and managed services provider, announced ... Partner Summit Country awards. Cisco named Softchoice ... the Year for Canada during its ... Montreal . "We are thrilled to ... year,s conference," said David MacDonald , Softchoice,s President and ...
(Date:5/1/2015)... TRIANGLE PARK, N.C. , May 1, 2015  United ... Roger Jeffs , Ph.D., President and Co-Chief Executive Officer of ... company,s business at the Deutsche Bank 40 th Annual ... The presentation will take place on Wednesday, May ... accessed via a live webcast on the United Therapeutics website ...
(Date:4/30/2015)... 30, 2015 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ... that it has commenced an underwritten public offering of ... the underwriters a 30-day option to purchase up to ... stock offered in the public offering. The offering is ... assurance as to whether or when the offering may ...
Breaking Biology Technology:Marianjoy Acquires Armeo®Spring Arm and Hand Rehabilitation Exoskeleton at Oakbrook Terrace Facility 2Softchoice recognized with two Country Awards at Cisco Partner Summit 2015 2BioAmber Inc. Announces Public Offering Of Common Stock 2BioAmber Inc. Announces Public Offering Of Common Stock 3
... Ltd. has begun,the second stage of its FDA ... brain tumors using MR guided Focused Ultrasound,Surgery on ... study are to evaluate the safety of focused,ultrasound ... the effect of,the thermal ablation on the tumors. ...
... ST. JOSEPH, Mich., Sept. 25 GeneGo, Inc., ... Bristol-Myers Squibb,(NYSE: BMY ) has licensed access ... technology, research and development sites within,Bristol-Myers Squibb will ... and/or genomics data to address questions from both ...
... team including scientists from the London Centre for Nanotechnology ... the National Academy of Sciences (PNAS) demonstrating the dramatic ... importance of the work lies in establishing how a ... at particle accelerators and nuclear reactors can be ...
Cached Biology Technology:InSightec Resumes Clinical Trials for Non-Invasive Treatment of Brain Tumors 2InSightec Resumes Clinical Trials for Non-Invasive Treatment of Brain Tumors 3GeneGo Enters Multi-Year Agreement With Bristol Myers Squibb for Access to GeneGo Software Suite and Databases 2Imaging quantum entanglement 2
(Date:4/17/2015)... , April 17, 2015 ... security concerns, and technological advancement to drive biometric ... until 2020   According to ... Arabia Biometric Systems Market Forecast &  Opportunities, 2020 ", biometric systems market ... projected to register growth at CAGR of over ...
(Date:4/10/2015)... , April 10, 2015 Research ... of the "Security Competitive Profiles - NEC" ... , NEC will continue to supply a ... the market, with a company focus on the development ... Winning opportunities in the Asia-Pacific ...
(Date:4/2/2015)... 2015 At its 2015 ACMG Annual Clinical ... , the American College of Medical Genetics and Genomics ... its Board.  Members of the ACMG Board of Directors ... and advancing its policies and programs. ACMG is the ... "It,s an eventful time in medical genetics and genomics.  ...
Breaking Biology News(10 mins):Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3NEC Security Competitive Profile 2015 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 3American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 4American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 5American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 6American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 7American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 8
... Mother Nature by developing, for the first time, ... tiny, hair-like structures through which organisms derive smell, ... new material isn,t exactly like cilia, it responds ... to control it and opening unlimited possibilities for ...
... BOSTONDana-Farber Cancer Institute,s Belfer Institute of Applied ... and NYSE: SNY) announced today that they have ... to identify and validate novel oncology targets ... novel therapeutics agents directed to such targets and ...
... Edward Yu of Iowa State University and the Ames Laboratory ... metal toxins from bacteria, making them resistant to antibiotics. ... of the journal Nature . Yu an ... of biochemistry, biophysics and molecular biology and an associate of ...
Cached Biology News:Cilia revolution 2Dana-Farber and sanofi-aventis establish cancer research alliance 2Iowa State, Ames Lab researchers identify structure that allows bacteria to resist drugs 2
Mouse monoclonal antibody to FMN2 - formin 2...
Mouse polyclonal antibody to ALS2CR8 - amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 8...
Rabbit polyclonal to SMARCA2 / BRM - ChIP Grade ( Abpromise for all tested applications). entrezGeneID: 6595 SwissProtID: P51531...
Determin interaction of your protein with Echelons lipids...
Biology Products: